Oral Drug Delivery News

  1. Micro-Sphere Expands HPAPI Capabilities At Swiss Site 10/24/2022

    Spray drying specialist and capsule filling service contract development and manufacturing organisation (CDMO) Micro-Sphere has invested over €5M to expand its GMP manufacturing capabilities at its facility in Monteggio, Switzerland.

  2. scPharmaceuticals Announces FDA Approval Of FUROSCIX® (Furosemide Injection) 10/11/2022

    scPharmaceuticals Inc. announced that the U.S. Food and Drug Administration (FDA) has approved FUROSCIX® (furosemide injection), a proprietary formulation of furosemide delivered via an On-Body Infusor for the treatment of congestion due to fluid overload in adults with New York Heart Association Class II/III chronic heart failure.

  3. Mikart and Nano PharmaSolutions Have Entered Into A Collaboration Agreement To Manufacture Clinical Trial Materials Using NanoTransformer™ Technology 10/11/2022

    Mikart, LLC ("Mikart") a comprehensive contract development and manufacturing organization announced that it has entered into a collaboration agreement with Nano PharmaSolutions, Inc. ("NPS"), an innovative nanotechnology company that has a proprietary NanoTransformer™ that enhances the solubility of pharmaceutical active ingredients (API).

  4. CEPI Partners With Intravacc To Develop An Intranasal, Broadly Protective Betacoronavirus Vaccine 10/6/2022

    CEPI, the Coalition for Epidemic Preparedness Innovations, and Dutch vaccine clinical development and manufacturing organization Intravacc, today announced the latest funding award under CEPI's US$200m program to advance the development of vaccines that provide broad protection against SARS-CoV-2 (including its variants) and other Betacoronaviruses.

  5. Nutriband With Kindeva Drug Delivery Demonstrate Enhanced Abuse-Deterrent Characteristics For Aversa™ Fentanyl 10/4/2022

    Studies at Kindeva Drug Delivery have demonstrated that Nutriband’s proprietary transdermal aversive coating can be manufactured using standard commercial transdermal manufacturing processes, which is critical to the success of the product development program.

  6. Hovione Expands Drug Product Offering With A New Manufacturing Line Dedicated To Continuous Tableting 9/6/2022

    Hovione, the leader in spray drying and particle engineering, announced today that it has expanded its continuous manufacturing offering and services. A new state-of-the-art continuous manufacturing facility is now coming online at the Loures site in Portugal

  7. CDMO Hovione Expands With New Manufacturing Line For Continuous Tableting Operations 9/6/2022

    Hovione, the leader in spray drying and particle engineering, announced today that it has expanded its continuous manufacturing offering and services. A new state-of-the-art continuous manufacturing facility is now coming online at the Loures site in Portugal.

  8. Zerion Pharma And Insud Pharma Announce Collaboration To Develop Dispersome Formulations Of Marketed Drug Products 8/29/2022

    The Danish pharmaceutical company Zerion Pharma A/S (ZERION) and the Spanish pharmaceutical group Insud Pharma, SL today are announcing their collaboration to develop and commercialize drug products applying ZERION’s solubility enhancing Dispersome technology

  9. Zerion Pharma And Hovione Extend Partnership To Cover Use Of The Dispersome® Technology Platform In Nutraceuticals 8/23/2022

    Hovione and Zerion Pharma A/S (Zerion) today announced an extension of their collaboration on Zerion's Dispersome® technology into the nutraceutical/dietary supplements field

  10. Evonik Now Offers Enteric Protected Ready To Fill Capsules EUDRACAP In IPEC GMP Quality 7/27/2022

    Evonik’s EUDRACAP enteric easy-to-handle capsules are now globally available produced under IPEC-GMP. Launched last year, EUDRACAP enteric are functional, ready-to-fill capsules that help pharmaceutical companies bring complex oral drug products to market faster